This report summarizes the new swine leukocyte antigen (SLA) allele sequences and haplotypes designated by the SLA Nomenclature Committee of the International Society for Animal Genetics. There have been 74 new SLA alleles, comprising 18 SLA-1 alleles, 11 SLA-2 alleles, six SLA-3 alleles, two SLA-6 alleles, one SLA-DRA allele, 20 SLA-DRB1 alleles, three SLA-DQA alleles and 13 SLA-DQB1 alleles. Twelve new SLA class I and four new class II haplotypes have also been designated. This is the first official update since the 2005 reports on the nomenclature for factors of the SLA class I and II systems. This report also summarizes recent updates
The International Society for Animal Genetics Nomenclature Committee for Factors of the Swine Leukocyte Antigen (SLA) System established the principles of a systematic nomenclature system for SLA genes and alleles that have been defined by means of DNA sequencing. Since the publication of the first nomenclature reports on the SLA class I (1) and class II (2) systems, there has been a considerable number of new and confirmatory sequences as well as SLA haplotype information accumulated. The SLA Nomenclature Committee has therefore decided to publish a report on recent updates to the Immunopolymorphism Database-Major Histocompatibility Complex (IPD-MHC) SLA sequence database that serves as the repository for maintaining a list of all recognized SLA genes and their allelic sequences.
The IPD-MHC SLA sequence database
The IPD-MHC SLA sequence database (http://www.ebi.ac. uk/ipd/mhc/sla/) has provided a repository for the sequences of the alleles designated by the SLA Nomenclature Committee for factors of the SLA system (3). This database is the primary source of information for the study of the polymorphic genes in the swine MHC system; it provides researchers a centralized platform to conveniently access the most recent nomenclature reports, maps of the SLA regions, lists of genes considered by the Committee as well as alleles recognized and their DNA and protein sequences. It also provides direct links to the alleles' associated publication abstracts and GenBank entries, phylogenetic analyses used for allele group assignment and lists of recognized SLA haplotypes. In addition, the IPD-MHC website offers researchers convenient access to multiple nucleotide and amino acid sequence alignments of all the recognized SLA alleles with various display options, which allow for more direct and effective comparisons within and between species. These features have helped to facilitate the analysis and study of SLA class I and II genes.
Since its initial release, a considerable number of new and confirmatory sequences have been submitted to the Chairman of the SLA Nomenclature Committee for consideration of allele designations. The list of all recognized SLA alleles and haplotypes has rapidly grown in size in the past several years. As such, the SLA Nomenclature Committee has performed a major update to the database, which includes all the SLA genes, alleles and haplotypes recognized to date, revisions to several allele designations, DNA and protein sequence alignments and the most recent phylogenies. Moreover, recent updates on the whole IPD-MHC website structure included the integration of an online submission tool at http://www.ebi.ac.uk/ipd/mhc/submit. html. This now allows direct and convenient submission of new and confirmatory sequences to the SLA Nomenclature Committee for the consideration of allele designations.
Naming of genes within the SLA region
Sequencing and mapping of the entire SLA region based on the common Hp-1.1 (H01) haplotype have been completed (4) . The genes in the SLA region considered by the SLA Nomenclature Committee are listed in Table 1 . This list of genes remains essentially unchanged from the first nomenclature reports (1, 2) , except that the putative SLA-wDYA pseudogene locus previously annotated between the class II DQ-DO interval will no longer be considered by the Committee because of insufficient evidence to support such annotation (4).
Naming of SLA alleles
The SLA Nomenclature Committee designates SLA alleles in parallel to the World Health Organization Human Leukocyte Antigen (HLA) Nomenclature System (1, 2). The naming conventions for SLA alleles are summarized in Table 2 . The first two digits are used to designate groups of alleles that have similar DNA sequences. Group designations are based on phylogenetic analysis and the identification of DNA sequence motifs that can be used for differentiation of alleles with the help of molecular methods (28) . The third and fourth digits are used to designate alleles with different protein sequences. The fifth and sixth digits are used to designate alleles that differ by synonymous nucleotide substitutions. The seventh and eighth digit would potentially be used to designate alleles with nucleotide substitutions outside the coding region that alter the protein expression. No such SLA alleles have been described to date.
In addition to the proposed use of 'N' or 'L' suffix to designate alleles that have no or a low protein expression, a 'Q' suffix is now used to designate alleles with profound sequence variations, which may significantly modify the expression as protein. This is demonstrated by the HLA-B*3565Q allele in which a nucleotide substitution is thought to affect its protein expression by disrupting the formation of a disulfide linkage (5) . Three SLA alleles to date have adopted these suffixes in their designations: SLA-DRB1*0603Q (formerly designated SLA-DRB1*060202) because of the characteristic absence of exon 5 that encodes an intracytoplasmic domain and SLA-DRB1*kb03N and SLA-DRB1*kb04N because of the presence of premature stop signals at codon 52.
As delineated in the previous SLA reports (1, 2), alleles that have been confirmed by more than one laboratory, in more than one pig breed or by a second DNA typing method are given official designations (conditions for acceptance of new allele sequences are also available at the IPD-MHC SLA website). Sequences that do not meet the requirements may be accepted but will be given a provisional alphanumeric allele name following the group designation (e.g. SLA-1*02we02) ( Table 2) . If the allele cannot be assigned to an existing group because of distinctive sequence motifs and/or insufficient sequence data, only a provisional alphanumeric allele name will be assigned (e.g. SLA-1*an01). A 'w' prefix is used to indicate a tentative allele group that does not contain any confirmed allele with official allele designation.
New allele sequences and groups
A total of 74 new SLA alleles have been named since the previous reports (Table 3 ). These comprised 18 SLA-1 alleles, 11 SLA-2 alleles, six SLA-3 alleles, two SLA-6 alleles, one DRA allele, 20 DRB1 alleles, three DQA alleles and 13 DQB1 alleles. Of the new alleles, 19 were confirmed either by more than one laboratory or by unique polymerase chain reaction-sequence-specific primer (PCR-SSP) patterns; thus, those 19 received official allele designations (four-digit allele name). Additionally, 22 previously published tentative alleles (with provisional alphanumeric names) were confirmed either by sequences identified in other breeds or laboratories; therefore, 21 of those 22 received official allele designations (the exception was SLA-1*an02 because of insufficient sequence data for a group assignment; Table 4 ). Based on the identification of the new sequences, three new allele groups have been designated: SLA-6*w04, SLA-DRB1*13 and SLA-DRB1*14.
Renaming of SLA alleles and groups
Because of the confirmation of alleles, several allele groups now have the provisional 'w' prefix omitted in the group designations, i.e., SLA-1*08, SLA-1*11-13, SLA-2*07, SLA-2*10-12 and SLA-DRB1*11. In addition, three SLA class II alleles have been renamed. SLA-DQB1*0401 now becomes SLA-DQB1*040101 because of the designation of SLA-DQB1*040102 in the Meishan pig breed, which differs synonymously at nucleotide (nt) 1270; this has been confirmed by PCR-SSP reactions (6) . SLA-DRB1*060201 was renamed SLA-DRB1*0602 after SLA-DRB1*060202 was renamed SLA-DRB1*0603Q because of its characteristic absence of the exon 5 coding region, which may significantly affect its protein expression.
On the other hand, the SLA-2*07rh12 that was derived from SLA class I haplotype Hp-14.0 (serotype H12) contains only partial exon 2 sequence (190 bp; nt 1149 to 338) and it matches SLA-2*0101, SLA-2*0102 and SLA-2*07we01. It was decided that this allele designation should remain in the database until further characterization is performed.
Polymorphism of the SLA genes
In the first SLA nomenclature reports (1, 2), there were 81 classical class I alleles (SLA-1, SLA-2 and SLA-3), seven nonclassical class I alleles (SLA-6) and 127 class II alleles (SLA-DRA, -DRB1, -DQA, -DQB1 and -DMA) with allele designations. As a result of this update, there are now a total of 125 class I alleles (44 SLA-1, 46 SLA-2, 26 SLA-3 and nine SLA-6) and 164 class II alleles (13 DRA, 82 DRB1, 20 DQA, 44 DQB1 and five DMA) with allele designations.
Classical SLA class I system
The SLA-1, SLA-2 and SLA-3 genes are highly polymorphic. There are 12 SLA-1 allele groups with a total of 44 alleles (including eight tentative alleles without group designation); 14 SLA-2 allele groups with a total of 46 alleles (including four tentative alleles without group designation) and seven SLA-3 allele groups with a total of 26 alleles (including one tentative allele without group designation).
Compared with the SLA-1 and SLA-3 alleles, the SLA-2 alleles have extra 9 bp in the leader sequence. In addition, several polymorphic sites appear to be locus specific for SLA-2 alleles. These are G at nt 111, C at nt 115, A at nt 120, A at nt 125, C at nt 128, A at nt 131 and T at nt 133. The only site that appears to be locus specific for SLA-3 alleles is the G at nt 1550. Locus-specific PCR primers have (27) recently been developed to distinguish most SLA-1 and SLA-3 alleles based on polymorphisms in the 3# untranslated region (6-9).
Nonclassical SLA class I system
The nonclassical SLA-6 gene appears to be largely monomorphic. There are only nine SLA-6 alleles representing four allele groups with very minor nucleotide substitutions between alleles. The extent of polymorphism of the SLA-7 and SLA-8 genes, on the other hand, has not been well characterized. There are only two reported alleles for each locus (10, 25) . Sequence comparisons showed that the SLA-7 alleles differ from each other at eight nucleotide positions, while the SLA-8 alleles differ from each other at seven positions.
SLA class II system
The SLA-DRB1 and -DQB1 loci display a very high degree of polymorphism. There are 14 SLA-DRB1 allele groups and a total of 82 alleles (including 21 tentative alleles without group designation) and nine SLA-DQB1 allele groups with a total of 44 alleles (including six tentative alleles without group designation). The SLA-DQA locus also exhibits a moderate degree of polymorphism with five allele groups and a total of 20 alleles (including one tentative allele without group designation). The SLA-DRA locus, on the other hand, exhibits a very limited polymorphism with 13 alleles representing three allele groups. This limited polymorphism is homologous to the HLA system; only three HLA-DRA alleles have been identified to date. Only one study has been published regarding the polymorphisms of the SLA-DMA locus (11) . This study characterized five SLA-DMA alleles that showed only a few nucleotide substitutions in exons 3 and 4. They were all designated as a single group. There are 16 alleles designated in the SLA-DRB pseudogene system (DRB2-DRB5). This number remains unchanged since the previous nomenclature report (2) . The extent of polymorphism of other SLA class II genes (DMB, DOA and DOB1) and pseudogenes (DQB2, wDYB and DOB2) also remains uncharacterized. There is only one sequence for each of these loci, which was derived from the only completely sequenced SLA haplotype Hp-1.1 (4).
Sequence length variations
Sequence length variations have been observed in several SLA alleles. Alleles assigned to the SLA-3*07 allele group have a distinctive 9-bp insertion in exon 2, which appears to result from a duplication of the preceding sequence (nt 1230 to 238). SLA-3*0402 and SLA-3*04es32 both have an identical 3-bp deletion in exon 3 (codon 150; nt 1510 to 512). SLA-3*04es32, in addition, has a unique 12-bp insertion in exon 4 (between nt 1744 and 1745). SLA-3*0501 has a distinctive 3-bp insertion in exon 5 (between nt 1939 and 1940). SLA-2*0302 and SLA-2*w09pt22 have an identical 6-bp deletion (codon 294-295; nt 1943 to 948) in exon 5. In the SLA-DQA system, all but the SLA-DQA*01 group alleles have an identical 3-bp insertion in exon 3 (between nt 1463 and 1464). SLA-DRB1*0603Q (formerly designated SLA-DRB1*060202), as mentioned previously, is missing in the entire exon 5 (24 bp), which encodes an intracytoplasmic domain of the mature DR b-chain protein.
Despite having such a profound sequence modification, this allele does not appear to be a sequence artifact as it has been detected independently in two porcine cDNA libraries constructed from the Landrace-Yorkshire commercial pigs (12, 13) and in a commercially available porcine embryonic kidney cell line (Ho CS, Franzo-Romain MH, Lee YJ, Lee JH, Smith DM, unpublished data). It is still not known which sequence length modifications may affect the structural integrity of the SLA proteins and thus modify their surface expression or function. It has been suggested that the three extra amino acids in the a1 domain of the SLA-3*07 group alleles should not significantly alter the structure of the peptide-binding groove; therefore, these alleles may still produce functional proteins (7) .
SLA haplotypes
In the previous nomenclature reports, there were 15 unique haplotypes (with one subtype Hp-4c.0 that differs from Hp-4a.0 at the SLA-6 locus) and four new class II haplotypes (with one subtype Hp-0.15b) designated. These resulted in a total of 26 unique class I haplotypes and 20 unique class II haplotypes (Tables 5 and 6 ). Duplication of the SLA-1 locus has now been observed in seven class I haplotypes (Hp-2.0, -8.0, -11.0, -12.0, -19.0, -20.0 and -27.0) ( Table 5 ). Phylogenetic analysis based on the exons 2 and 3 coding regions is still unable to differentiate alleles between these loci. Based on the observation of a crossover in the Sinclair and Hanford miniature pig crosses, SLA-1*0201 of Hp-2.0 and SLA-1*w09sm09 of Hp-11.0 have been assigned to the centromeric SLA-1 locus, whereas SLA-1*0701 and SLA-1*0101 have been assigned to the telomeric SLA-1 locus in their respective haplotypes (Ho et al., unpublished data) .
Crossover regions in the recombinant SLA haplotypes of the National Institutes of Health (NIH) and Clawn miniature pigs have recently been studied using microsatellite markers (14) . An identical crossover point was mapped to the class III region near the complement C2 locus of the recombinant haplotypes Hp-2.4 and Hp-3.4 (previously designated h and g, respectively) in the NIH miniature pigs. An additional crossover point was also observed in Hp-2.4 in the class I region telomeric to the MIC-2 locus. In the Clawn miniature pigs, a crossover point was mapped to a 208-kb fragment in the class I region of the recombinant Hp-16.17, while two different crossover points were observed in the recombinant Hp-17.16 in the class I region centromeric to the SLA-11 locus and near the nonclassical class I genes.
Conclusion
Overall, this systematic nomenclature for SLA class I and II alleles is critical for further development of research in swine immunology and diseases as well as the use of swine as transplantation models and xenotransplantation donors. It facilitates communication about SLA alleles and haplotypes, particularly in outbred pigs. MHC proteins play a central role in the presentation of antigenic peptides to T cells and updated nomenclature and knowledge of SLA alleles will be extremely useful in the study of cell-mediated immunity to pathogens and vaccine development (15) .
